Neurology
The neurology therapeutics market has experienced extensive R&D efforts in the past decade, which have resulted in the introduction of novel drug-delivery systems and new technologies, like gene or cell-therapy. The advancements in the field of biotherapeutics are expected to increase the adoption of novel therapies to treat neurological diseases.
​
The global neurology therapeutic market size was valued at 116 bn USD in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2021 to 2028, exceeding 200 bn USD. By far the biggest share in the therapeutics market is held by CNS cancer therapeutics and drugs for the treatment of Mental health diseases.
​
As advancements in diagnostics and therapeutics of nervous system diseases are expected to increase the treatment rate globally, so will the stringency of payers and HTA-bodies increase, in their attempt to impede excessing healthcare expenditure.
Global Neurology therapeutics market share, by disease 2020 (%)
​
We support our clients in every aspect of pharmaceutical excellence, including product strategy, process transformation and capability enhancement.
​
This means harnessing available data sources, utilization of digital platforms, navigation through a changing Payer & Reimbursement landscape and collaboration with academic centers and patient organizations, in order to demonstrate value to decision-making audiences.
​
In addition, by focusing on emerging new technologies and analytics, which are driving change throughout the pharma industry value chain, we will support you strengthen your competitive position to better meet the changing needs of your audiences.